Entries of Weishaupt, Carsten on the publication server

Becker, Jürgen C, Ugurel, Selma, Leiter, Ulrike, Meier, Friedegund , Gutzmer, Ralf, Haferkamp, Sebastian, Zimmer, Lisa, Livingstone, Elisabeth, Eigentler, Thomas K , Hauschild, Axel, Kiecker, Felix, Hassel, Jessica C, Mohr, Peter, Fluck, Michael, Thomas, Ioannis , Garzarolli, Marlene, Grimmelmann, Imke, Drexler, Konstantin, Spillner, Alexandra N, Eckhardt, Sebastian, Schadendorf, Dirk, van Akkooi, Alexander, van Houdt, Winan, Wilhelm, Tabea, Farmer, Kimberley, Ulrich, Claas, Gambichler, Thilo, Bluhm, Leonie, Schinagl, Heidemarie, Kellner, Ivonne, Herbst, Rudolf, Meiß, Frank, Rafei-Shamsabadi, David, Sell, Sabine, Kaatz, Martin, Wulfken, Lena, Hartmann, Martin, Kähler, Katharina, Ziemer, Mirjana, Simon, Jan, Terheyden, Patrick, Thaci, Diamant, Loquai, Carmen, Mitzel-Rink, Heidrun, Grabbe, Stephan, Stege, Henner, Gaiser, Maria, Utikal, Jochen, Berking, Carola, Heinzerling, Lucie, Schlaak, Max, Tomsitz, Dirk, Dyballa, Jörg, Magnolo, Nina, Weishaupt, Carsten, Berneburg, Mark, Garbe, Claus, Flatz, Lukas, Gesierich, Anja and Schilling, Bastian (2023) Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial. The Lancet 402 (10404), pp. 798-808. Fulltext not available.

Zaremba, Anne, Mohr, Peter, Gutzmer, Ralf, Meier, Friedegund , Pföhler, Claudia, Weichenthal, Michael, Terheyden, Patrick, Forschner, Andrea, Leiter, Ulrike, Ulrich, Jens, Utikal, Jochen, Welzel, Julia, Kaatz, Martin, Gebhardt, Christoffer , Herbst, Rudolf, Sindrilaru, Anca, Dippel, Edgar, Sachse, Michael, Meiss, Frank , Heinzerling, Lucie, Haferkamp, Sebastian, Weishaupt, Carsten, Löffler, Harald, Kreft, Sophia, Griewank, Klaus, Livingstone, Elisabeth, Schadendorf, Dirk, Ugurel, Selma and Zimmer, Lisa (2023) Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG. European Journal of Cancer 188, pp. 140-151. Fulltext not available.

Schumann, Katharina, Mauch, Cornelia, Klespe, Kai‐Christian, Loquai, Carmen, Nikfarjam, Ulrike, Schlaak, Max, Akçetin, Larissa, Kölblinger, Peter, Hoellwerth, Magdalena , Meissner, Markus, Mengi, Guelcin, Braun, Andreas Dominik , Mengoni, Miriam, Dummer, Reinhard, Mangana, Joanna, Sindrilaru, Mihaela‐Anca, Radmann, Dan, Hafner, Christine, Freund, Johann, Rappersberger, Klemens, Weihsengruber, Felix, Meiss, Frank, Reinhardt, Lydia, Meier, Friedegund , Rainer, Barbara, Richtig, Erika, Ressler, Julia Maria , Höller, Christoph, Eigentler, Thomas , Amaral, Teresa, Peitsch, Wiebke K., Hillen, Uwe, Harth, Wolfgang, Ziller, Fabian, Schatton, Kerstin, Gambichler, Thilo, Susok, Laura, Maul, Lara Valeska, Läubli, Heinz, Debus, Dirk, Weishaupt, Carsten, Börger, Sevil, Sievers, Katharina, Haferkamp, Sebastian, Zenderowski, Veronika, Nguyen, Van Anh, Wanner, Marina, Gutzmer, Ralf, Terheyden, Patrick, Kähler, Katharina, Emmert, Steffen, Thiem, Alexander, Sachse, Michael, Gercken‐Riedel, Silke, Kaune, Kjell Matthias, Thoms, Kai‐Martin, Heinzerling, Lucie, Heppt, Markus Vincent, Tratzmiller, Sabine, Hoetzenecker, Wolfram, Öllinger, Angela, Steiner, Andreas, Peinhaupt, Tobias, Podda, Maurizio, Schmid, Sabine, Wollina, Uwe, Biedermann, Tilo and Posch, Christian (2023) Real‐world outcomes using PD‐1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland. Journal of the European Academy of Dermatology and Venereology 37 (5), pp. 894-906. Fulltext not available.

Franklin, Cindy , Mohr, Peter, Bluhm, Leonie, Grimmelmann, Imke, Gutzmer, Ralf, Meier, Friedegund , Garzarolli, Marlene, Weichenthal, Michael , Pfoehler, Claudia, Herbst, Rudolf , Terheyden, Patrick, Utikal, Jochen, Ulrich, Jens, Debus, Dirk, Haferkamp, Sebastian, Kaatz, Martin, Forschner, Andrea, Leiter, Ulrike, Nashan, Dorothee, Kreuter, Alexander, Sachse, Michael, Welzel, Julia, Heinzerling, Lucie, Meiss, Frank, Weishaupt, Carsten, Gambichler, Thilo, Weyandt, Gerhard, Dippel, Edgar, Schatton, Kerstin, Celik, Eren, Trommer, Maike, Helfrich, Iris, Roesch, Alexander, Zimmer, Lisa , Livingstone, Elisabeth, Schadendorf, Dirk, Horn, Susanne and Ugurel, Selma (2022) Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG. Journal for ImmunoTherapy of Cancer 10 (6), e004509. Fulltext not available.

Kreft, Sophia, Glutsch, Valerie, Zaremba, Anne, Schummer, Patrick , Mohr, Peter, Grimmelmann, Imke, Gutzmer, Ralf, Meier, Friedegund , Pföhler, Claudia, Sachse, Michael Max, Meiss, Frank, Forschner, Andrea, Haferkamp, Sebastian, Welzel, Julia, Terheyden, Patrick, Herbst, Rudolf, Utikal, Jochen, Kaatz, Martin, Weishaupt, Carsten, Kreuter, Alexander, Debus, Dirk, Duecker, Pia, Sindrilaru, Anca, Löffler, Harald, Schley, Gaston, Weichenthal, Michael, Schadendorf, Dirk, Ugurel, Selma, Gesierich, Anja and Schilling, Bastian (2022) MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma – An evaluation of the multicenter prospective skin cancer registry ADOREG. European Journal of Cancer 167, pp. 32-41. Fulltext not available.

Mohr, Peter, Scherrer, Emilie, Assaf, Chalid, Bender, Marc , Berking, Carola, Chandwani, Sheenu, Eigentler, Thomas , Grimmelmann, Imke, Gutzmer, Ralf , Haferkamp, Sebastian, Hassel, Jessica , Hauschild, Axel , Herbst, Rudolf , Jiang, Ruixuan , Kähler, Katharina, Krepler, Clemens, Kreuter, Alexander , Leiter, Ulrike, Loquai, Carmen, Meier, Friedegund , Pföhler, Claudia, Rudolph, Anja, Schadendorf, Dirk, Schiavone, Maximo, Schley, Gaston, Terheyden, Patrick, Ugurel, Selma , Ulrich, Jens, Utikal, Jochen , Weishaupt, Carsten , Welzel, Julia and Weichenthal, Michael (2022) Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany. Cancers 14 (7), p. 1804. Fulltext not available.

van Akkooi, Alexander C. J., Haferkamp, Sebastian, Papa, Sophie, Franke, Viola, Pinter, Andreas, Weishaupt, Carsten, Huber, Margit A., Loquai, Carmen, Richtig, Erika, Gokani, Priya, Öhrling, Katarina, Louie, Karly S. and Mohr, Peter (2021) A Retrospective Chart Review Study of Real-World Use of Talimogene Laherparepvec in Unresectable Stage IIIB–IVM1a Melanoma in Four European Countries. Advances in Therapy 38 (2), pp. 1245-1262. Fulltext not available.

Zaremba, Anne, Philip, Manuel, Hassel, Jessica C., Glutsch, Valerie, Fiocco, Zeno, Loquai, Carmen, Rafei-Shamsabadi, David , Gutzmer, Ralf, Utikal, Jochen, Haferkamp, Sebastian , Reinhardt, Lydia, Kähler, Katharina C., Weishaupt, Carsten, Moreira, Alvaro, Thoms, Kai-Martin, Wilhelm, Tabea, Pföhler, Claudia, Roesch, Alexander, Ugurel, Selma, Zimmer, Lisa , Stadtler, Nadine, Sucker, Antje, Kiecker, Felix, Heinzerling, Lucie, Meier, Friedegund, Meiss, Frank, Schlaak, Max, Schilling, Bastian, Horn, Susanne, Schadendorf, Dirk and Livingstone, Elisabeth (2021) Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases. European Journal of Cancer 152, pp. 139-154. Fulltext not available.

Knispel, Sarah, Gassenmaier, Maximilian, Menzies, Alexander M., Loquai, Carmen, Johnson, Douglas B., Franklin, Cindy , Gutzmer, Ralf, Hassel, Jessica C., Weishaupt, Carsten, Eigentler, Thomas, Schilling, Bastian, Schummer, Patrick , Sirokay, Judith , Kiecker, Felix, Owen, Carina N., Fleischer, Maria I., Cann, Christopher, Kähler, Katharina C., Mohr, Peter, Bluhm, Leonie, Niebel, Dennis , Thoms, Kai-Martin, Goldinger, Simone M., Reinhardt, Lydia, Meier, Friedegund, Berking, Carola, Reinhard, Raphael, Susok, Laura, Ascierto, Paolo A., Drexler, Konstantin, Pföhler, Claudia, Tietze, Julia, Heinzerling, Lucie, Livingstone, Elisabeth, Ugurel, Selma, Long, Georgina V. , Stang, Andreas, Schadendorf, Dirk and Zimmer, Lisa (2021) Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition. European Journal of Cancer 148, pp. 61-75. Fulltext not available.

Angela, Yenny , Haferkamp, Sebastian, Weishaupt, Carsten, Ugurel, Selma, Becker, Jürgen C., Oberndörfer, Florian, Alar, Vesna, Satzger, Imke and Gutzmer, Ralf (2019) Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastases. Cancer Immunology, Immunotherapy 68 (7), pp. 1187-1194. Fulltext not available.